The $5 Billion Failure: Why Criminalization Fuels Canada's Drug Crisis and How Treatment Saves $12
By Rachel Urbas | Certified MHFA Instructor & Psychoeducational Facilitator > Fact-checked & Updated: July 2026
With more than 18 people dying every single day from opioid toxicity, the crisis of substance use disorder (SUD) in Canada is a full-blown public health catastrophe.
The sheer scale of national mortality, surpassing 53,800 deaths since 2016, is a direct consequence of an escalating toxic drug supply, the complexities of polysubstance use, and persistent systemic barriers to care.
Addressing this national challenge requires a unified, Health-First strategy that integrates our neuroscientific understanding of dependence with immediate and essential social and policy reforms.
Key Takeaways
- The Biological Reality: Substance use disorder (SUD) is a chronic, relapsing brain disease, not a moral failing. Potent substances hijack the brain's natural reward pathways and shut down endorphin and GABA systems, turning pleasure seeking into physical survival needs.
- The Fiscal Failure: Canada's de facto punitive approach and criminalization carry a massive financial burden, costing over $5 billion annually. Incarcerating a single individual costs up to $140,000 per year, delivering zero therapeutic benefit.
- The Health-First Return: Shifting to a public health model with Medication-Assisted Treatment (MAT) and Supervised Consumption Sites (SCS) saves lives, prevents disease transmission, and delivers a massive return on investment—saving up to $12 for every $1 spent.
The Neurobiological Underpinning of Addiction
Understanding addiction begins with its biological roots in the brain’s reward system. This circuit’s natural purpose is to motivate survival behaviors, encouraging us to do things like eat, exercise, and connect with others.
It works by releasing a powerful, feel-good chemical messenger called dopamine. When we do something beneficial, dopamine is released, reinforcing that behaviour. Psychoactive substances, however, don't just participate in this system; they hijack it entirely.
Instead of the gentle, natural dopamine release, these substances flood the brain, creating an overwhelming surge that can be 2 to 10 times more intense than any natural reward. This overwhelming chemical response is the engine that drives dependence and lays the groundwork for addiction.
The Biology of Dependence: How Drugs Hijack the Brain
Because some substances mimic the structure of endorphins (our body’s natural painkillers), they fit perfectly into the brain's mu-opioid receptors. When they bind to these receptors, they simultaneously block pain signals and trigger a rapid release of dopamine.
Highly potent synthetic opioids, such as fentanyl, cause a rapid reaction in the brain. Because the brain perceives this sudden, massive chemical surge as an imbalance, it halts its own production of natural endorphins to protect itself. This severe chemical deficit is why dependence sets in so fast, leaving the system in immediate, agonizing withdrawal when the drug clears.
Alcohol and Benzodiazepines: The Brake System Failure
Alcohol and prescription sedatives, such as Valium and Xanax, manipulate a very different neural pathway, which is the brain's primary inhibitory system. These substances work by binding to GABA (gamma aminobutyric acid) receptors, which slow down nerve activity to reduce anxiety and induce calm.
Over time, the brain attempts to offset this constant, drug-induced sedation. To find equilibrium, it diminishes its calming GABA receptors while simultaneously ramping up its active, stimulating glutamate signals.
When the substance is suddenly removed, this delicate balance collapses. The calming effect instantly vanishes, leaving the central nervous system in a state of extreme, uninhibited overactivity. This sudden hyperexcitation triggers dangerous, potentially fatal withdrawal symptoms, such as grand mal seizures.
Long-Term Rewiring: The Shift from Pleasure to Need
Chronic substance use causes lasting, physical changes to both the structure and function of the brain. This change is rooted in the prefrontal cortex, the area of the brain that controls impulses, decisions, and future planning.
Long-term drug and alcohol use damages these neural pathways, making it incredibly difficult for a person to stop compulsive behaviours, even when those behaviours cause severe harm.
Additionally, recent studies show that chronic neuroinflammation, which is persistent swelling in brain tissue, helps drive this cycle. This ongoing inflammation alters mood and choice, which increases the risk of relapse and worsens co-occurring mental health issues.
With long-term use of alcohol or drugs, the brain stops chasing a high. Instead, it begins relying on the substance just to function and feel normal. The goal changes from chasing pleasure to avoiding severe physical and mental distress.
The Evolving Crisis: Data, Demographics, and Policy Failure
The addiction crisis in Canada has changed dramatically. While it once centered on prescription painkillers, it is now dominated by the illegal street market, where contaminated drugs like fentanyl have taken over.
This shift has driven a rise in polysubstance use, where stimulants like methamphetamine and cocaine are combined with or contaminated by opioids. This trend complicates both emergency medical responses, because naloxone cannot reverse stimulant toxicity, and long-term treatment strategies.
Key Provincial Mortality Data
Canada's opioid toxicity crisis is a national tragedy, yet its severity and manifestation are divided along provincial lines.
The crisis is geographically uneven, highlighting a failure in national policy harmonization and a differential impact of local governance.
The mortality data across the provinces reveals a disturbing trend where high death tolls persist, often serving as the backdrop for contentious public health debates.
British Columbia: The Epicentre of Progressive Response
Long recognized as the epicentre, B.C. has consistently maintained one of the highest per capita rates of overdose deaths in the country.
Tragically, in recent years, B.C. has seen its annual death toll consistently surpass 2,500 lives lost (B.C. Coroners Service, 2024). This rate reflects an environment saturated with the highly potent, illicit drug supply, dominated by synthetic opioids like fentanyl.
B.C.'s progressive approach to harm reduction, including a high concentration of Supervised Consumption Sites (SCS), the push for a Safer Supply initiative (prescribing pharmaceutical alternatives to the toxic street drug supply), and the small-scale decriminalization of personal possession, has been implemented as an urgent response to, rather than a successful prevention of, the extreme mortality rates.
Alberta: Conservative Policies and Devastating Losses
Alberta has also experienced devastating opioid mortality, with the province recording over 1,800 substance-related deaths in the most recent 12-month period (Alberta Health Services, 2024). While the per capita rate may fluctuate, the absolute number underscores a significant public health failure.
Conservative provincial governments in Alberta have often prioritized abstinence-only and treatment-on-demand models, leading to friction over established harm reduction strategies.
This approach resulted in policy friction and the politically driven closure or severe restriction of many existing Supervised Consumption Sites (SCS), based on arguments concerning neighborhood disruption, a move health experts warned would likely exacerbate deaths.
Alberta's data illustrates a direct policy choice favouring one model over another, with immense consequences.
Ontario: High Volume and Policy Variation
While the province's per capita rate often falls between the extreme highs of B.C. and the mixed policies of the Prairie provinces, the volume is shocking, with Ontario reporting an annual death toll exceeding 2,800 (Ontario Public Health, 2024).
Ontario’s approach to the crisis is fragmented because policies are managed by individual municipalities. Major urban centers like Toronto and Ottawa offer well-established support networks, whereas smaller, rural, and northern regions face a severe shortage of services.
This geographic imbalance creates "deserts of care" that lead to unequal health outcomes across the province.
Canadian Policy as a Determinant of Death
Data from British Columbia, Alberta, and Ontario shows that the opioid crisis is not the same everywhere. Instead, it is a series of local health emergencies shaped by different government decisions.
However, death rates remain high and continue to rise in all of these provinces. This shows that current policies are failing to stop the spread of toxic drugs.
To stop these rising deaths across Canada, we need a unified national plan. This plan must use proven tools like harm reduction and easy access to treatment, while still letting local cities adjust the rules for their own needs.
Health Equity and Vulnerable Populations
The overdose crisis disproportionately impacts the most marginalized in Canadian society because of deep-seated structural inequities—specifically the Social Determinants of Health (SDOH)—that create a cumulative vulnerability to drug use, addiction, and fatal overdose.
Addiction is most often not caused by personal choices. Instead, it is driven by systemic issues that force specific groups of people into high-risk situations with very few resources.
Indigenous Populations: The Legacy of Colonialism and Systemic Racism
The most tragic disparity is seen among Indigenous Peoples (First Nations, Métis, and Inuit), who face mortality rates significantly higher than the non-Indigenous population (e.g., in B.C., First Nations people have died from opioid toxicity at over five times the rate of other residents).
The historical and ongoing impacts of colonization, the Residential School system, the Sixties Scoop, and land dispossession have resulted in intergenerational trauma, creating chronic emotional and spiritual distress.
Indigenous people often face racialized violence and discrimination within the healthcare, justice, and social service systems, leading to delayed or inadequate access to culturally safe harm reduction and treatment options.
Socioeconomic Marginalization and Poverty
There is a clear socioeconomic gradient in substance-related harms, meaning the lower the income and socioeconomic status (SES), the higher the rates of death, hospitalization, and emergency department visits.
People experiencing houselessness or precarious housing are at an extremely high risk. They often use drugs alone, in unsafe public spaces, or in emergency shelters, all of which increase the likelihood of a fatal overdose, particularly from the toxic street supply.
Justice System Involvement and Stigma
Criminalizing drug use represents a public health failure that disproportionately impacts marginalized populations, particularly racialized and low-income communities.
While Canada's official drug strategy is framed around public health and harm reduction, the ongoing criminalization of drug possession maintains a de facto punitive system.
A de facto punitive system is one that functions to punish people through its actions and consequences, even if its stated intent is social welfare or rehabilitation.
In drug policy, a system operates this way when it officially claims a public health mission but continues to rely heavily on policing, arrests, and incarceration.
This dynamic drives profound health inequities, as evidenced by the severe over-representation of Indigenous Peoples in federal custody (e.g., comprising over 32% of inmates despite being only ~5% of the general population).
This systemic bias is compounded by intense social stigma, which is reinforced by criminal laws. This stigma serves as a primary barrier that prevents individuals from seeking help or accessing critical healthcare services, such as supervised consumption sites.
Most importantly, this social pressure forces people to use drugs in isolation. Using alone is the single greatest risk factor for a fatal overdose within a toxic drug supply.
Consequently, the involvement of the justice system and the resulting social stigma act as powerful structural drivers of Canada's ongoing mortality crisis.
Disrupting the "Revolving Door" of Substance Use
Canada is focused on disrupting the "revolving door" of addiction, crime, and relapse by strategically shifting away from a punitive approach toward a public health model.
This shift is most notably embodied by the move toward decriminalization, which directly confronts the legal and social barriers faced by People Who Use Drugs (PWUD).
The core goal is to reduce arrests, mitigate the trauma and instability caused by interaction with the justice system, and encourage PWUD to seek necessary help without the paralyzing fear of criminal charges, a policy stance being explored by other jurisdictions as well.
Mental Health and Drug Diversion Courts
These specialized courts are designed to interrupt the repetitive patterns of drug addiction and imprisonment by redirecting non-violent offenders from jail into supervised, long-term treatment programs.
Rather than undergoing traditional sentencing, participants receive court-monitored therapy, regular drug testing, and social support.
Despite their documented success in lowering re-offending rates, these courts remain underutilized due to significant structural challenges that limit their availability.
Police Discretion and Training
Inconsistent training across law enforcement agencies means that individuals experiencing a crisis are frequently arrested and jailed rather than being referred to treatment programs or diversion courts.
This lack of standardization leads to significant disparities based on geography or individual officer bias. Despite federal policy changes intended to prioritize healthcare over criminalization, drug possession remains the most frequent drug-related charge laid by police, and studies confirm that referrals to specialized drug treatment courts and diversion pathways remain extremely low —often utilized in less than 5% of eligible simple possession cases across major urban centers (Department of Justice Canada, 2023).
Logistical Failures
Diversion programs require participants to attend frequent court hearings, counseling sessions, and medical appointments. Individuals experiencing houselessness, lacking reliable transportation, or facing unstable employment often struggle to meet these strict demands, resulting in Failure to Appear notices.
These missed appearances can lead to arrest warrants, which disqualify participants from the program and return them to the standard criminal justice system.
Availability
Many rural or underserved communities simply lack the resources, funding, or trained judicial and medical staff to implement or sustain these specialized courts.
Comprehensive Treatment, Recovery, and Dual Diagnosis
Effective addiction treatment is not a single intervention but a sustained care continuum. It must integrate pharmacotherapy, psychoeducation, and social supports.
Integrated Care and Dual Diagnosis
It is estimated that over 50% of people with SUD also have a co-occurring condition (e.g., depression, anxiety, PTSD, bipolar disorder, psychosis)—also known as dual diagnosis or co-occurring disorders.
Integrated care models utilize clinical teams of addiction specialists, psychiatrists, and therapists to deliver coordinated psychotherapy and medical treatment in a single location. These therapies often include Cognitive Behavioral Therapy and Dialectical Behavior Therapy.
Failing to treat mental health and substance use disorders at the same time significantly increases the likelihood of relapse. Furthermore, individuals with co-occurring disorders face a much higher risk of suicidal ideation and suicide attempts compared to those with only one diagnosis.
The relationship between mental health challenges and substance use creates a complex, worsening crisis that drives a disproportionate number of deaths, including suicide, across Canada.
Medication-Assisted Treatment (MAT)
These medicines are the most effective way to help the brain heal and recover from opioid addiction. They work by gently stabilizing the brain chemistry that has been thrown out of balance by substance use.
Buprenorphine-Naloxone (Suboxone)
This is the most common MAT option and is often prescribed for use at home. The main medicine, buprenorphine, acts like a partial blocker.
It sits in the brain’s opioid receptors—the same spots where other opioids attach—but only provides a mild, steadying effect. This is enough to stop intense cravings and prevent painful withdrawal symptoms without causing the strong, addictive "high" of full opioids.
The second component, naloxone, acts as a safeguard. If someone were to dissolve and inject the medicine, the naloxone immediately triggers withdrawal. This safety feature makes it possible to prescribe Suboxone for use in outpatient care or at home.
Methadone
Methadone is a powerful, long-acting treatment given at specialized clinics. Methadone is a full stabilizer.
When taken, it completely fills the opioid receptors, stopping all withdrawal symptoms and blocking the euphoric effects of other opioids a person might take.
Because it lasts a long time, it provides a very stable level of support for the brain. However, it requires a commitment to daily visits at a licensed clinic for dosing and involves closer, strict monitoring from medical staff.
The Harm Reduction Imperative: A Life-Saving and Fiscally Responsible Investment
Harm reduction is a non-judgmental approach focused on minimizing the negative consequences of drug use rather than demanding immediate abstinence.
In the context of the highly toxic fentanyl crisis, this is a life-saving measure that also proves to be a fiscally responsible investment for the Canadian state.
Supervised Consumption Sites (SCS) and Prevention
SCS, or Consumption and Treatment Services (CTS), provide a safe, hygienic, monitored space for individuals to consume pre-obtained drugs.
The evidence from sites across Canada, like Insite in Vancouver, is undeniable:
Zero Overdose Fatalities: No one has ever died of an overdose in an SCS, despite staff intervening in thousands of events (Health Canada, 2024).
Reduced Disease Transmission: SCS and Needle and Syringe Programs lead to significantly lower rates of sharing equipment, contributing to lower community transmission of blood-borne diseases like HIV and Hepatitis C (Canadian Institute for Health Information, 2023).
Pathways to Care: SCS serve as non-stigmatizing entry points, linking users to vital services, including housing, medical care, and Medication-Assisted Treatment (MAT).
The Economic Justification: Cost of Crime vs. ROI of Treatment
The enormous, recurring cost of criminalization and incarceration pales in comparison to the proven, long-term returns on investing in treatment and harm reduction.
The current policy of criminalizing drug use carries a massive financial burden, with the overall economic cost of the opioid crisis, including health-care and lost productivity, estimated to exceed $5 billion annually(Public Health Agency of Canada, 2023).
The direct cost is staggering, as the average annual cost of housing one federal inmate is approximately $130,000 to $140,000(Correctional Service of Canada, 2024)—a fee paid repeatedly for people cycling in and out of the justice system with zero therapeutic benefit. Conversely, public health investments generate net savings:
Medication-Assisted Treatment (MAT) Return
Studies consistently show that every dollar invested in MAT saves between four and twelve dollars in reduced crime, lower healthcare utilization (fewer emergency room visits and hospital stays), and judicial costs over five years.
The fact that treatment for Substance Use Disorder (SUD) generates a $12 saving for every $1 invested is highly significant because it translates to a remarkable 1200% return on investment.
Housing First Programs
For unhoused individuals with SUD, providing stable housing unconditionally first dramatically reduces police interactions and costly detox admissions.
These programs are fiscally prudent, often achieving net savings by saving provincial and municipal governments more than the cost of housing itself.
Every fatal overdose requires extensive, expensive crisis response (first responders, forensics); by preventing a single death and keeping people stable in treatment, these interventions avoid hundreds of thousands of dollars in crisis costs and drastically reduce the chronic burden on the emergency healthcare system.
Conclusion: The Path Forward
The crisis of substance use disorder in Canada demands a response that matches the complexity of the disease itself.
As this analysis shows, addiction is rooted in neurobiology, exacerbated by systemic inequalities, and amplified by policy failures. Recovery is not a single path, but a comprehensive system built on three interconnected pillars:
Clinical Interventions: Ensuring universal and immediate access to evidence-based pharmacotherapies (Medication-Assisted Treatment) and integrated care for co-occurring mental health disorders (dual diagnosis).
Harm Reduction: Expanding the life-saving infrastructure of Supervised Consumption Sites and mandating the widespread distribution of naloxone to stabilize individuals and reduce preventable deaths caused by the contaminated illicit supply.
Structural Reform: Treating addiction as a public health issue by implementing widespread decriminalization for simple possession, replacing justice-system penalties with medical interventions, and actively combating all forms of structural stigma.
The enormous recurring costs of criminalization and incarceration pale in comparison to the proven, long-term returns on investing in treatment, housing, and social supports.
The challenge facing Canada is not a lack of solutions, but a lack of unified resolve. A full commitment to this evidence-based, Health-First model enables Canada to move beyond the current landscape of crisis toward a future of stability, recovery, and genuine human potential.
Take the Next Step: Be Prepared for Crisis
You now understand the science and policy of addiction. Are you prepared to offer immediate support during a mental health or substance use crisis? Learn the practical steps needed to help someone until professional assistance arrives. See our Mental Health First Aid guide.
Do you work with youth? We offer specialized Mental Health First Aid training for adulting supporting youth.
